Worth Asset Management’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Worth Asset Management’s Portfolio BBC Stock Details BBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-4,093	Closed	-$216K	–	231
2026 Q2	$216K	Buy	+4,093	New	+$183K	0.07%	193

Other funds holding BBC

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Dynamic Wealth Strategies Granite Bay, California $188M AUM 12.25% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

Worth Asset Management's BBC Position: Q3 2026 in Review

Worth Asset Management sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q3 2026, closing a stake of 4,093 shares — an estimated $216K sold.

Worth Asset Management first reported a position in BBC in Q2 2026 and held it in 1 quarter. The position peaked at $216K in Q2 2026. 3 funds tracked by Wall St. Rank hold BBC as of Q3 2026.

Worth Asset Management reported no remaining Virtus Biotech Clinical Trials ETF position as of Q3 2026 after selling out during the quarter.
Worth Asset Management sold 4,093 Virtus Biotech Clinical Trials ETF shares in Q3 2026, an estimated $216K.
Worth Asset Management first reported a position in Virtus Biotech Clinical Trials ETF in Q2 2026 and held it in 1 quarter.
Worth Asset Management's Virtus Biotech Clinical Trials ETF position peaked at $216K in Q2 2026.
3 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2026.

Based on Worth Asset Management's 13F filing for Q3 2026, filed 7 Oct 2026.